Company: CWAN
Filing Date: 2025-03-06
Form Type: S-4/A
Source: 0001193125-25-048570
Chunk: 75

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-03-06
Form: S-4/A
Chunk 75
---
 notice of and to vote at the Special Meeting is , 2025 (referred to as the record date). Virtual Participation at the Special Meeting The Special Meeting will be a completely virtual meeting of stockholders conducted via live audio webcast through the website described above under the heading “Date, Time and Place.” Only Enfusion Stockholders who held shares of record as of the close of business on the record date are entitled to receive notice of and vote at the Special Meeting and any adjournment or postponement of the Special Meeting, as long as such shares remain outstanding on the date of the Special Meeting. Enfusion’s official stock ownership records will conclusively determine whether a stockholder is a “holder of record” as of the record date. Enfusion will have technicians ready to assist Enfusion Stockholders with any technical difficulties they may have accessing the virtual meeting. If Enfusion Stockholders encounter any difficulties accessing the virtual meeting or during the meeting time, Enfusion Stockholders should navigate to where a phone number for IT support will be posted. 45

Outstanding Shares as of the Record Date

As of the record date, there were shares of Enfusion Common Stock and Enfusion Class B Common Stock
outstanding and owned by stockholders (i.e., excluding shares of Enfusion Common Stock held in treasury by Enfusion), held by holders of record. Each share of Enfusion Common Stock and Enfusion Class B Common Stock
is entitled to one vote on each matter considered at the Special Meeting.

Enfusion Stockholders may request an appointment to inspect a
complete list of stockholders entitled to vote at the Special Meeting for any purpose germane to the Special Meeting at Enfusion’s headquarters located at 125 South Clark Street, Suite 750, Chicago, Illinois 60603 during ordinary business hours
within ten days prior to the Special Meeting by sending an email request to investors@enfusion.com.

Shares and Voting of Enfusion’s Directors and Executive Officers

As of the record date, Enfusion directors and executive officers, as a group, owned
and were entitled to vote shares of Enfusion Common Stock and Enfusion Class B Common Stock, or approximately % of the outstanding shares of Enfusion Common Stock and Enfusion Class B Common Stock.
Enfusion currently expects that these directors and executive officers will vote their shares in favor of the Merger Agreement Proposal and the Adjournment Proposal, although none of the directors and executive officers, other than Oleg Movchan with
respect to the Merger Agreement Proposal and the Adjourn